WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched on MAY 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PROSTATIC ADENOCARCINOMA IN IRAQI PATIENTS WITH CLINICOPATHOLOGICAL CORRELATION: A RETROSPECTIVE STUDY

Dr. Dalya Zuhair Basheer* and Prof. Dr. Khitam Razzak Al-Khafaji

ABSTRACT

Introduction: The rise in prostate cancer (PCa) morbidity and mortality over the years has led to widespread screening and early detection, especially for high-risk groups, as well as advancements in various treatment options. PCa encompasses a range of diseases. The study’s objective is to determine the relationship between prostatic adenocarcinoma's age, Gleason score, grade, and perineural invasion. Method: Cross-sectional research of 160 male adenocarcinoma patients at Ghazi Al-Hariri teaching hospital for surgical specialties and private laboratory from January 2019 to December 2022. All patients get age, procedures, peri neural invasion, Gleason score, and grades. No exceptions. Results: 160 prostatic adenocarcinoma patients, mean age 65.6 ± 9.7 years, cross-sectional research. 37.5% of patients aged 60-69, 31.3% aged 70-79. 98.8% had prostatic biopsies. 17.5% had positive peri neural invasion.46.25% had 4+4 Gleason scores, 16.25% have 3+4, and 9.38% have 4+3 and 4+5. 48.75% of patients were grade 4, 18.75% grade 5, and 16.25% grade 2. Peri neural invasion is associated with Gleason score: 100% of patients with 5+3=8 have positive peri neural invasion, 64.7% of patients with 4+5=9 do too. All Gleason 3+3=6, 3+5=8, 5+4=9, and 5+5=10 patients exhibit negative perineural invasion. Age, procedures, and grade do not affect perineural invasion. Conclusion: our study highlights the significant association between Gleason score and Peri neural invasion in prostatic adenocarcinoma, while revealing no associations with age, biopsy procedures, or cancer grade. These findings underscore the heterogeneity and complexity of the disease, emphasizing the need for personalized assessment and treatment strategies.

[Full Text Article] [Download Certificate]